Role of GERD in chronic resistant sinusitis: A prospective, open label, pilot trial

John K. DiBaise, Bolarinwa F. Olusola, James V. Huerter, Eamonn M M Quigley

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

OBJECTIVE: The objective of this study was to determine whether aggressive medical therapy of gastroesophageal reflux disease (GERD) could improve both subjective and objective features of chronic resistant sinusitis (CRS). METHODS: Consecutive patients with CRS underwent assessment of GERD and sinus symptoms, esophageal motility testing, dual-channel esophageal pH testing, and laryngoscopy and nasal endoscopy at baseline. The results were compared to those of a group of GERD patients without sinus problems. The CRS patients alone then received omeprazole 20 mg b.i.d, for 3 months with symptom follow-up at monthly intervals. Laryngoscopy and nasal endoscopy were repeated at 3 months. RESULTS: Eleven patients with CRS and 19 GERD patients participated. Eight CRS patients experienced heartburn at least once weekly. Esophageal manometry and pH test results were similar between the two groups. Nine CRS patients had an abnormal pH test. All 11 CRS patients completed the 3-month course of omeprazole. Individual sinus symptoms (nasal congestion, nasal drainage, sinus pressure, facial headache, malaise) and global satisfaction were modestly improved in 25-89% and 91%, respectively, at 12 wk. Resolution of symptoms occurred infrequently. We identified no baseline variable that could predict symptom improvement. Although laryngoscopy and nasal endoscopy were abnormal in most CRS patients at baseline and improved in some after treatment, these changes did not parallel symptom improvement. CONCLUSION: In this small, prospective, open label study, we demonstrated a high prevalence of GERD in patients with CRS, many of whom experienced modest sinus symptom improvement after using omeprazole b.i.d. for 3 months. These findings warrant further randomized, controlled study in a larger patient population.

Original languageEnglish (US)
Pages (from-to)843-850
Number of pages8
JournalAmerican Journal of Gastroenterology
Volume97
Issue number4
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Sinusitis
Gastroesophageal Reflux
Laryngoscopy
Omeprazole
Nose
Endoscopy
Paranasal Sinuses
Heartburn
Manometry
Headache
Drainage
Pressure

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Role of GERD in chronic resistant sinusitis : A prospective, open label, pilot trial. / DiBaise, John K.; Olusola, Bolarinwa F.; Huerter, James V.; Quigley, Eamonn M M.

In: American Journal of Gastroenterology, Vol. 97, No. 4, 2002, p. 843-850.

Research output: Contribution to journalArticle

DiBaise, John K. ; Olusola, Bolarinwa F. ; Huerter, James V. ; Quigley, Eamonn M M. / Role of GERD in chronic resistant sinusitis : A prospective, open label, pilot trial. In: American Journal of Gastroenterology. 2002 ; Vol. 97, No. 4. pp. 843-850.
@article{ff9757039c774010808185503d5cf738,
title = "Role of GERD in chronic resistant sinusitis: A prospective, open label, pilot trial",
abstract = "OBJECTIVE: The objective of this study was to determine whether aggressive medical therapy of gastroesophageal reflux disease (GERD) could improve both subjective and objective features of chronic resistant sinusitis (CRS). METHODS: Consecutive patients with CRS underwent assessment of GERD and sinus symptoms, esophageal motility testing, dual-channel esophageal pH testing, and laryngoscopy and nasal endoscopy at baseline. The results were compared to those of a group of GERD patients without sinus problems. The CRS patients alone then received omeprazole 20 mg b.i.d, for 3 months with symptom follow-up at monthly intervals. Laryngoscopy and nasal endoscopy were repeated at 3 months. RESULTS: Eleven patients with CRS and 19 GERD patients participated. Eight CRS patients experienced heartburn at least once weekly. Esophageal manometry and pH test results were similar between the two groups. Nine CRS patients had an abnormal pH test. All 11 CRS patients completed the 3-month course of omeprazole. Individual sinus symptoms (nasal congestion, nasal drainage, sinus pressure, facial headache, malaise) and global satisfaction were modestly improved in 25-89{\%} and 91{\%}, respectively, at 12 wk. Resolution of symptoms occurred infrequently. We identified no baseline variable that could predict symptom improvement. Although laryngoscopy and nasal endoscopy were abnormal in most CRS patients at baseline and improved in some after treatment, these changes did not parallel symptom improvement. CONCLUSION: In this small, prospective, open label study, we demonstrated a high prevalence of GERD in patients with CRS, many of whom experienced modest sinus symptom improvement after using omeprazole b.i.d. for 3 months. These findings warrant further randomized, controlled study in a larger patient population.",
author = "DiBaise, {John K.} and Olusola, {Bolarinwa F.} and Huerter, {James V.} and Quigley, {Eamonn M M}",
year = "2002",
doi = "10.1016/S0002-9270(02)03954-0",
language = "English (US)",
volume = "97",
pages = "843--850",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Role of GERD in chronic resistant sinusitis

T2 - A prospective, open label, pilot trial

AU - DiBaise, John K.

AU - Olusola, Bolarinwa F.

AU - Huerter, James V.

AU - Quigley, Eamonn M M

PY - 2002

Y1 - 2002

N2 - OBJECTIVE: The objective of this study was to determine whether aggressive medical therapy of gastroesophageal reflux disease (GERD) could improve both subjective and objective features of chronic resistant sinusitis (CRS). METHODS: Consecutive patients with CRS underwent assessment of GERD and sinus symptoms, esophageal motility testing, dual-channel esophageal pH testing, and laryngoscopy and nasal endoscopy at baseline. The results were compared to those of a group of GERD patients without sinus problems. The CRS patients alone then received omeprazole 20 mg b.i.d, for 3 months with symptom follow-up at monthly intervals. Laryngoscopy and nasal endoscopy were repeated at 3 months. RESULTS: Eleven patients with CRS and 19 GERD patients participated. Eight CRS patients experienced heartburn at least once weekly. Esophageal manometry and pH test results were similar between the two groups. Nine CRS patients had an abnormal pH test. All 11 CRS patients completed the 3-month course of omeprazole. Individual sinus symptoms (nasal congestion, nasal drainage, sinus pressure, facial headache, malaise) and global satisfaction were modestly improved in 25-89% and 91%, respectively, at 12 wk. Resolution of symptoms occurred infrequently. We identified no baseline variable that could predict symptom improvement. Although laryngoscopy and nasal endoscopy were abnormal in most CRS patients at baseline and improved in some after treatment, these changes did not parallel symptom improvement. CONCLUSION: In this small, prospective, open label study, we demonstrated a high prevalence of GERD in patients with CRS, many of whom experienced modest sinus symptom improvement after using omeprazole b.i.d. for 3 months. These findings warrant further randomized, controlled study in a larger patient population.

AB - OBJECTIVE: The objective of this study was to determine whether aggressive medical therapy of gastroesophageal reflux disease (GERD) could improve both subjective and objective features of chronic resistant sinusitis (CRS). METHODS: Consecutive patients with CRS underwent assessment of GERD and sinus symptoms, esophageal motility testing, dual-channel esophageal pH testing, and laryngoscopy and nasal endoscopy at baseline. The results were compared to those of a group of GERD patients without sinus problems. The CRS patients alone then received omeprazole 20 mg b.i.d, for 3 months with symptom follow-up at monthly intervals. Laryngoscopy and nasal endoscopy were repeated at 3 months. RESULTS: Eleven patients with CRS and 19 GERD patients participated. Eight CRS patients experienced heartburn at least once weekly. Esophageal manometry and pH test results were similar between the two groups. Nine CRS patients had an abnormal pH test. All 11 CRS patients completed the 3-month course of omeprazole. Individual sinus symptoms (nasal congestion, nasal drainage, sinus pressure, facial headache, malaise) and global satisfaction were modestly improved in 25-89% and 91%, respectively, at 12 wk. Resolution of symptoms occurred infrequently. We identified no baseline variable that could predict symptom improvement. Although laryngoscopy and nasal endoscopy were abnormal in most CRS patients at baseline and improved in some after treatment, these changes did not parallel symptom improvement. CONCLUSION: In this small, prospective, open label study, we demonstrated a high prevalence of GERD in patients with CRS, many of whom experienced modest sinus symptom improvement after using omeprazole b.i.d. for 3 months. These findings warrant further randomized, controlled study in a larger patient population.

UR - http://www.scopus.com/inward/record.url?scp=0036120430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036120430&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(02)03954-0

DO - 10.1016/S0002-9270(02)03954-0

M3 - Article

C2 - 12003417

AN - SCOPUS:0036120430

VL - 97

SP - 843

EP - 850

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -